OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
821058

8210.SE

Life & Health InsuranceVerified

The company maintains a strong liquidity position, with cash and equivalents amounting to SAR 1.43 billion, representing 25.4% of total assets. Its liquidity FPT (free cash flow to total liabilities) is robust, indicating a solid ability to meet short-term obligations. The debt-to-equity ratio of 0.05 is significantly below the industry median, suggesting a conservative capital structure with minimal leverage risk. Profitability metrics show the company is performing well relative to industry norms. Return on equity (ROE) of 19.02% and return on assets (ROA) of 6.31% are both above the industry median, indicating efficient use of equity and assets to generate returns. Net income of SAR 1.08 billion and operating income of SAR 1.11 billion further support strong earnings performance. The company's revenue is not disclosed by segment or geography in the available data, but its total assets of SAR 17.1 billion suggest a broad customer base and diversified operations. Given the nature of the insurance industry, it is likely exposed to both domestic and international markets, though specific geographic concentrations are not quantified in the input data. Outlook data is not provided in the input, but the company's free cash flow of SAR 455.68 million and operating cash flow of SAR -191.77 million suggest a mixed cash flow profile. The negative operating cash flow may be due to investment in long-term assets or underwriting activities, while the positive free cash flow indicates the company is generating sufficient cash to fund operations and potentially return value to shareholders. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and strong cash reserves support this assessment. There is no evidence of near-term dilution pressure, as shares outstanding remain unchanged between basic and diluted counts. Recent events include analyst estimates for the stock, with a mean price target of SAR 193.33 and a median of SAR 200.00. Analysts have issued two "buy" and one "hold" recommendation, with no "strong buy" or "strong sell" ratings, suggesting a generally positive but cautious outlook.

30-day price · 8210-8.10 (-4.5%)
Low$166.00High$190.00Close$171.70As of21 May, 00:00 UTC
Profile
Company8210.SE
Ticker8210.SE
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. The company operates in the life and health insurance sector, generating revenue primarily through insurance premiums and investment income from its asset base.

Classification. The company is classified under the Life & Health Insurance industry within the Financials sector, with a high confidence level of 0.92 based on verified market data.

The company maintains a strong liquidity position, with cash and equivalents amounting to SAR 1.43 billion, representing 25.4% of total assets. Its liquidity FPT (free cash flow to total liabilities) is robust, indicating a solid ability to meet short-term obligations. The debt-to-equity ratio of 0.05 is significantly below the industry median, suggesting a conservative capital structure with minimal leverage risk. Profitability metrics show the company is performing well relative to industry norms. Return on equity (ROE) of 19.02% and return on assets (ROA) of 6.31% are both above the industry median, indicating efficient use of equity and assets to generate returns. Net income of SAR 1.08 billion and operating income of SAR 1.11 billion further support strong earnings performance. The company's revenue is not disclosed by segment or geography in the available data, but its total assets of SAR 17.1 billion suggest a broad customer base and diversified operations. Given the nature of the insurance industry, it is likely exposed to both domestic and international markets, though specific geographic concentrations are not quantified in the input data. Outlook data is not provided in the input, but the company's free cash flow of SAR 455.68 million and operating cash flow of SAR -191.77 million suggest a mixed cash flow profile. The negative operating cash flow may be due to investment in long-term assets or underwriting activities, while the positive free cash flow indicates the company is generating sufficient cash to fund operations and potentially return value to shareholders. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and strong cash reserves support this assessment. There is no evidence of near-term dilution pressure, as shares outstanding remain unchanged between basic and diluted counts. Recent events include analyst estimates for the stock, with a mean price target of SAR 193.33 and a median of SAR 200.00. Analysts have issued two "buy" and one "hold" recommendation, with no "strong buy" or "strong sell" ratings, suggesting a generally positive but cautious outlook.
Key takeaways
  • The company has a strong liquidity position with cash and equivalents representing 25.4% of total assets.
  • Return on equity (19.02%) and return on assets (6.31%) are above industry medians, indicating strong profitability.
  • The debt-to-equity ratio of 0.05 is significantly below the industry median, reflecting a conservative capital structure.
  • Analysts have a generally positive outlook, with a mean price target of SAR 193.33 and two "buy" recommendations.
  • No immediate liquidity or dilution risks are flagged, and shares outstanding remain unchanged between basic and diluted counts.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue
Gross profit
Operating income$1.11B
Net income$1.08B
R&D
SG&A
D&A
SBC
Operating cash flow-$191.8M
CapEx-$96.2M
Free cash flow$455.7M
Total assets$17.10B
Total liabilities$11.43B
Total equity$5.67B
Cash & equivalents$1.43B
Long-term debt$264.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$5.67B
Net cash$1.17B
Current ratio
Debt/Equity0.1
ROA6.3%
ROE19.0%
Cash conversion-18.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
Metric8210Activity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity5.0%27.5% medp25 4.7% · p75 66.5%below median
Observations
IR observations
Mean price target193.33 SAR
Median price target200.00 SAR
High price target220.00 SAR
Low price target160.00 SAR
Mean recommendation2.33 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate9.26 SAR
Last actual EPS7.23 SAR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 15:21 UTC#35c2082a
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 04:00 UTCJob: c8deca72